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Abstract While there are many reports in the
literature describing the attributes of speciﬁc appli-
cations of transgenic animals for agriculture, there are
relatively few studies focusing on the ﬁtness of the
transgenic animals themselves. This work was
designed to gather information on genetically mod-
iﬁed food animals to determine if the presence of a
transgene can impact general animal production
traits. More speciﬁcally, we used a line of transgenic
dairy goats expressing human lysozyme in their
mammary gland to evaluate the reproductive ﬁtness
and growth and development of these animals
compared to their non-transgenic counterparts and
the impact of consuming a transgenic food product,
lysozyme-containing milk. In males, none of the
parameters of semen quality, including semen vol-
ume and concentration, total sperm per ejaculate,
sperm morphology, viability and motility, were
signiﬁcantly different between transgenic bucks and
non-transgenic full-sib controls. Likewise, transgenic
females of this line did not signiﬁcantly differ in the
reproductive traits of gestation length and litter size
compared to their non-transgenic counterparts. To
evaluate growth, transgenic and non-transgenic kid
goats received colostrum and milk from either
transgenic or non-transgenic does from birth until
weaning. Neither the presence of the transgene nor
the consumption of milk from transgenic animals
signiﬁcantly affected birth weight, weaning weight,
overall gain and post-wean gain. These results
indicate that the analyzed reproductive and growth
traits were not regularly or substantially impacted by
the presence or expression of the transgene. The
evaluation of these general parameters is an impor-
tant aspect of deﬁning the safety of applying trans-
genic technology to animal agriculture.
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Introduction
The health and welfare of animals raised for produc-
tion purposes is of central importance to the public
and producers. For successful applications of genetic
engineering (GE) to be included in animal production
systems, the health and welfare of these animals must
be considered. This would also help to improve the
perception of the use of transgenic animals in
agriculture as well as public perception of biotech-
nology in general. Currently, no transgenic animal
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DOI 10.1007/s11248-010-9371-zproducts are approved for consumption. The adoption
of transgenesis as an effective tool for animal
improvement will not be accepted for commercial
use until the questions of the health and welfare of
transformed animals are addressed.
The ﬁrst attempts at GE in animals resulted in
some physiological problems in the transgenic ani-
mals, attributed to inappropriate control of transgene
expression resulting in over expression or expression
in undesirable tissues (Pursel et al. 1990). Coupling
the gene construct to a promoter with appropriate
tissue speciﬁcity and expression patterns decreased
negative welfare impacts due to transgenic expression
(Pursel et al. 2004). However, transgenes introduced
by microinjection are randomly integrated into the
genomic DNA and disruption of endogenous genes
can potentially lead to deleterious results. Studies
which evaluate general animal production parameters
are therefore helpful in assessing the overall health of
a transgenic line.
Animal welfare however is a concept that involves
both physical and subjective evaluations of transgenic
lines (Dennis 2002; Buehr et al. 2003; Duncan 2005;
Wells et al. 2006; Mertens and Rulicke 2007). Van
Reenen (2009) has suggested that observations
regarding the welfare of a transgenic line should be
made at times of transgene expression as well as at
different stages of life including gestation and birth,
birth to puberty and a period representative of adult
life, such as reproductive performance. Therefore, to
evaluate the general physical aspects of animal health
and welfare, standard measures of reproductive ﬁtness
such as semen quality in males and such indices as
number of live young born, number of dead born,
gestation length, and days to ﬁrst heat cycle can be
used as indicators of reproductive health in females.
Another key indicator of health in living organisms is
the ability to grow from birth to adulthood in a manner
similar to other young of the species. A multitude of
factors can affect the growth of an animal such as
quality and quantity of feed, management, housing,
disease, and temperature. In terms of transgenic
animals, the introduction of a foreign gene may also
affect the animal depending on the site of transgene
integration into the genome and potential interactions
of the transgene product in the animal.
Speciﬁc studies focusing on the health and welfare
of the GE livestock are lacking in the literature. Here,
we begin to quantify the impact of transgene presence
and expression on general parameters of animal health
in our human lysozyme (hLZ) line of transgenic dairy
goats. The hLZ line was generated by pronuclear
microinjection with a transgene consisting of the hLZ
cDNA linked to a bovine as1-casein promoter to direct
expression of hLZ to the mammary gland (Maga et al.
2003). The transgene is transmitted in a Mendelian
fashion (Maga et al. 2006a) and we have maintained
the line as hemizygous, currently through the ﬁfth
generation. The transgene is expressed in milk at
levels of 270 lg/ml without disrupting gross milk
composition or milk production parameters (Maga
et al. 2006a). The impact of transgene expression has
been well-characterized as milk containing the anti-
microbial hLZ protein was capable of slowing the
growth of mastitis- and cold spoilage-causing bacteria
in vitro and increasing shelf-life (Maga et al. 2006b),
modulating the levels of coliforms and E. coli in the
intestine of kid goats and young pigs upon consump-
tion of the milk (Maga et al. 2006c) resulting in a
healthier intestinal morphology, resistance to infec-
tion by E. coli (Brundige et al. 2008) and a serum
metabolite proﬁle of indicative of improved gut health
(Brundige et al. 2009).
All results described for this line of transgenic
animals to date have been congruent with predictions
based on the action of lysozyme expression in the
mammary gland. In terms of the impact of the
presence of the transgene on the transgenic animal
itself, questions as to if the basic functions of these
animals are in any way compromised due to the
presence and expression of the hLZ transgene have
yet to be addressed. This paper examines the growth
and reproductive ﬁtness of male and female hLZ
transgenic goats and their full-sib controls with the
intent of determining if these key production param-
eters are affected by the genomic integration of the
hLZ transgene. Additionally, the health of animals
consuming milk with increased levels of lysozyme
was assessed to determine the impact of consumption
of a transgenic product, speciﬁcally milk.
Materials and methods
Growth trials
Growth trials were conducted over the three-year
period between 2006 and 2008. Does were bred in the
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123fall to produce kids between late February and early
June. Animals enrolled in the study consisted of all
offspring from matings between either transgenic
males and non-transgenic control females or trans-
genic females and non-transgenic control males. All
non-transgenic animals used for breeding were of the
same background as the transgenic line (Alpine and
Toggenburg in origin). At birth, both male and
female kids were randomly placed into one of two
feeding groups with one group receiving colostrum
and milk from hLZ transgenic does, and the other
receiving colostrum and milk from non-transgenic
control does. Transgenic status of each kid was
determined by taking ear and umbilical tissue sam-
ples at birth and performing transgene-speciﬁc PCR
(Maga et al. 2003) to determine by day 2 of the trial
whether or not the animal carried the transgene. Thus,
for each type of milk, there were both transgenic and
non-transgenic animals consuming it in order to
determine transgene impact, milk impact and any
interactions between these variables. In the ﬁnal year
of the study animals were non-randomly assigned to
groups to ensure an equal distribution of male and
female animals in each of the four groups. Animals
were removed from the study if euthanasia was
required due to injury or illness. Table 1 shows the
number of animals that completed the study from
birth to weaning.
In all years of the study, kids were removed from
does at birth and each was hand-fed 240–300 ml
heat-treated (57C for 60 min then frozen until
needed) colostrum from individual does from their
designated feeding group (hLZ or control milk)
within 12 h after birth. The kids were then bottle-
fed 240–350 ml of pasteurized hLZ or control milk
three times daily to approximately 4 days of age
when free-choice cooler-feeding was implemented.
Standard Thermos
 coolers were converted to kid
feeders by drilling holes in the front of the cooler and
ﬁtting rubber nipples in the holes. Coolers were
cleaned and ice packs were changed once per day to
keep the milk cool and avoid spoilage. The appro-
priate pasteurized milk was added to each cooler at
least twice a day so that each kid received approx-
imately 0.95 l milk/kid/day when younger and up to
2.8 l milk/kid/day as they grew older. This feeding
strategy is standard procedure at our dairy goat
facility. Milk for feeding was collected from indi-
vidual hLZ transgenic (n = 8 year 1, n = 11 year 2,
n = 11 year 3) and non-transgenic control does
(n = 54 in all years) by machine twice daily and
pooled into respective containers. Each pool of milk
was batch pasteurized to 74C prior to feeding to kids
to reduce transmission of caprine arthritis encepha-
litis virus (CAEV) and other diseases (Greenwood
1993; Peterhans et al. 2004). Pools of milk were
typically fed within 3 days or less after pasteuriza-
tion, and milk older than 7 days was discarded.
Prior to weaning, kids were housed at an indoor
animal facility in large cardboard refrigerator boxes
until approximately 2-weeks of age, at which time
they were moved to group pens with wood shavings
and straw for bedding. At 6 weeks of age, they were
offered alfalfa hay and pellets, and 4 weeks later beef
trace mineral salts. At 110 days of age the animals
were weaned. At this time they were moved to
outdoor pens, and separated into same-sex groups
that were housed adjacent to each other. All animals
were housed and cared for according to AAALAC
guidelines.
Reproduction—males
To reduce genetic variation between control and
transgenic goats, all full sib males resulting from the
breeding of a hLZ transgenic animal and a non-
transgenic control animal were used. Non-transgenic
control animals used for breeding were Toggenburg,
Alpine or crosses of these breeds (the background of
the transgenic line). Over three breeding seasons,
from 2006 to 2008, a total of 12 control bucks and 12
transgenic bucks were evaluated. Each buck had the
semen from his ﬁrst breeding season evaluated. In
addition, in the third year of the study, two hLZ
transgenic bucks from the previous year (1 year
167 days old) were included to compare semen
parameters from their ﬁrst year to their second year
Table 1 Distribution of animals completing the feeding trial
(birth to weaning)
C
aC
b CT TC TT
Females 6 8 5 4
Males 9 8 5 8
a First letter of column heading designates animal type
(C = Control, T = Transgenic)
b Second letter of column indicates type of milk fed
(C = Control, T = Transgenic)
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123as the bucks matured. First year bucks in the study
were between 205 and 282 days of age and between
18 and 30 kg at the time of the semen collection.
Bucks were housed with does occupying adjoining
pens to encourage reproductive behavior. Bucks were
fed alfalfa hay and pellets daily with unlimited access
to fresh water.
Semen collection began at the end of September
and continued through early December. All bucks
were collected twice, at least 3 days apart, to remove
sperm accumulation in the week prior to analysis.
Animals were then collected two more times at least
3 days apart for analysis. Collection was accom-
plished with an artiﬁcial vagina (AV) and a doe in
heat. Temperature of the water in the AV was
maintained at approximately 38–40C. A graduated
collecting tube attached to the disposable sleeve
inside the AV was used to evaluate volume of semen
collected. Semen parameters analyzed included vol-
ume, concentration, total sperm per ejaculate, mor-
phology, viability and motility (total motility and
total progressive motility).
Immediately after collection and determination of
volume of ejaculate, semen samples were transferred
to the laboratory. In 2006, analysis of the semen was
done in a room heated to 41C, and in 2007, the
semen was kept in an incubator at 41C. Gross
motility and color of semen were recorded at this
time, but not reported here. A portion of the semen
was extended 1:999 with water and sperm concen-
tration (billions sperm/ml ejaculate) was determined
using a hemocytometer under a microscope at 4009.
Two counts were made for each individual and
averaged. If the counts differed by 30% or more, the
concentration was reanalyzed using another aliquot of
the same sample.
For the remainder of the analyses, the remaining
semen was extended 10:990 with buffer consisting of
68 mM sodium citrate, 25 mM sodium bicarbonate,
5.4 mM potassium chloride, 16.7 mM glucose,
17.4 mM sulfanilamide, 10% fresh chicken egg yolk
(fresh eggs deﬁned as eggs laid within 24 h), 5,000 IU
penicillin and 0.8 mM streptomycin. Viability was
measured using a sperm viability stain kit (Fertility
Solutions Inc., Cleveland, OH). After staining of
spermwithNigrosinandEosin-Y,countsoflivesperm
per 100 were conducted under a microscope using a
1009 objective and a 109 eyepiece. Percent normal
morphology was determined with a morphology stain
(Lane Manufacturing Inc., Denver, CO). Number of
normal sperm out of 100 was determined under a
microscope at 1,0009.
Preliminary trials in 2006 to evaluate motility of
sperm were carried out, with data for analysis
collected in 2007 and 2008 only. Total progressive
and forward motility were determined using the
CASA (Computer-Aided Sperm Analysis) system.
Prior to assaying sperm motility, samples were
diluted to between 25 9 10
6 and 50 9 10
6 cells per
milliliter to accommodate the parameters of the
CASA system.
Reproduction—females
Information on the reproductive ﬁtness of does was
determined by the number of live, dead, and total kids
born as well as gestation length. Does were matched
for breed, age and parity for the analysis with non-
transgenic control does. Dead kids were classiﬁed as
kids who died within 3 days of birth. Birthing records
from 2001 to 2008 were analyzed to determine the
kidding history of does. These records followed the
reproductive history of 15 control and 9 transgenic
does that were related to the founder to, in some
cases, the 6th parity. The number of observations
among all the does over the 8 years was 82. The same
population of bucks was used for the mating of both
transgenic and control does. All animals used in the
study were cared for under AAALAC-approved
conditions.
Statistical analysis
Animal weights in 2006 and 2007 were recorded at
birth, as well as twice a week to weaning, and at 8, 12
and 16 weeks post-weaning. In 2008 animals were
weighed at birth and at weeks 1, 3, 8, 10, 11 and 13.
No post-wean weights were recorded in 2008. Data
for weaning weights for statistical analysis was
obtained from weights at 14 weeks for 2006 and
2007, and in 2008 at 11 and 13 weeks. Only animals
that completed the trial from birth to weaning were
included in the statistical analysis. All values are
reported as the mean ± SD.
A Proc Mixed Ratio ANCOVA analysis using
SAS 9.1 (Cary, NC) was used to detect differences
between transgenic and control animals. For the
growth data, differences due to transgene, milk, birth
980 Transgenic Res (2010) 19:977–986
123weight and year effects were determined. Since the
rate of growth for males is higher than that of females
(Lawrence and Fowler 1997), the data for each sex
were separated for analysis. Litter size and birth
weight are inversely related in the dairy goat (Salah
et al. 1989). Generally animals which demonstrate a
lighter than average birth weight will eventually
catch up in size to their contemporaries (Lawrence
and Fowler 1997). However, to accurately assess
growth in a study where litter size ranged from 1 to 4,
both litter size and birth weight were analyzed as
classes of covariables in an ANCOVA (data not
shown). Birth weight had a smaller mean square error
and was therefore used instead of litter size as a class
covariate in the ﬁnal model (birth weight MSE
= 6.807, litter size MSE = 8.850). An ANCOVA
was run with gain analyzed as a function of type of
animal, milk consumed, birth weight and year of trial.
REGWQ was used as the test to determine which
group means were different from each other.
For reproduction data, males were grouped by the
class (type/year/breed) to which they belonged. Age
and weight were additional covariates that were
tested in the analysis. Due to the continuous nature of
the age (by days) and weight covariables, the Proc
Mixed analysis was necessary. For gestation length
and number of kids born type/breed identiﬁers were
used, and parity and age were additional covariates.
A chi-squared test was used to determine differences
in the number of kids born dead. For both data sets,
all tests were performed at the 95% conﬁdence level
and assumptions of normality of residuals and normal
distribution were tested using Levene’s test of
homogeneity and Shapiro–Wilk, respectively. No
abnormalities were detected.
Results
Growth
Over the 3 years of the trial (2006–2008), no
signiﬁcant differences were detected in the mean
birth weights between transgenic and non-transgenic
control females (P = 0.71) or males (P = 0.51;
Table 2). In addition, there were no signiﬁcant
differences in mean birth weights among the 3 years
of the study in both females and males (P = 0.44 and
P = 0.83, respectively). Results of the growth
analysis from birth to post-weaning are presented in
Table 3. There were no signiﬁcant differences in
overall gain among all groups of females (P = 0.17)
or males (P = 0.63) as well as no differences due to
year (P = 0.06 females, P = 0.57 males). Weaning
weights were not signiﬁcantly different for females
(P = 0.11) or males (P = 0.67) of all groups. There
was no effect of year on weaning weight in males
(P = 0.67) but there was for females (P = 0.05).
Females of all groups did not gain weight at
signiﬁcantly different rates (P = 0.09) and the slope
of gain for males of all groups was also not
signiﬁcantly different (P = 0.42). There was a
signiﬁcant differences in slope by year for both
females and males (P = 0.008 and P = 0.0083,
respectively). The post-wean gain in weight was not
signiﬁcantly different among any group of males
(P = 0.49) nor was there a year effect (P = 0.60).
Post-wean gain in females was not signiﬁcantly
different by year (P = 0.52) or by group (P = 0.19).
To evaluate the impact of consuming hLZ milk, an
ANCOVA was run including birth weight, year and
milk type as co-variables. Neither birth weight, year,
nor type of milk consumed affected the overall
growth (birth to wean) of transgenic females
(P = 0.80, 0.96 and 0.90, respectively), non-trans-
genic females (P = 0.88, 0.56 and 0.55, respec-
tively), transgenic males (P = 0.53, 0.08 and 0.19
respectively) and non-transgenic males (P = 0.30,
0.71 and 0.68, respectively). To analyze the impact of
the transgene, an ANCOVA was performed using
birth weight, year and transgenic status as co-
variables. Overall growth (birth to wean) of animals
consuming non-transgenic milk was not impacted by
the presence of the transgene, birth weight or year of
the trial (P = 0.50, 0.70 and 0.66, respectively for
females and P = 0.65, 0.62 and 0.67, respectively
for males). Similar results were found for the
Table 2 Mean birth weights (kg) of hLZ transgenic and non-
transgenic control animals
Control
a Transgenic
a
Females 3.68 ± 0.59
(n = 14)
3.65 ± 0.65
(n = 9)
Males 3.76 ± 0.83
(n = 17)
3.98 ± 0.41
(n = 12)
a No signiﬁcant differences were detected between control and
transgenic animals (P[0.05)
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There were no signiﬁcant differences in transgene
status, birth weight or year for both females (0.17,
0.92 and 0.12, respectively) and males (P = 0.73,
0.94 and 0.67, respectively).
Reproduction
Measures of reproductive ﬁtness in the bucks through-
out the 3 years of the study are reported in Tables 4,
5,6.Nosigniﬁcantdifferencesbetweentransgenicand
non-transgenic control males were detected in semen
volume (P = 0.61), concentration (P = 0.86), total
sperm per ejaculate (P = 0.86), morphology (P = 0.15)
or viability (P = 0.55) (Table 4). No signiﬁcant
differences in semen motility were demonstrated
between the two groups of animals in terms of both
totalmotility(P = 0.50)andtotalprogressivemotility
(P = 0.41; Table 5). Table 6 compares the semen
parametersintwotransgenicbucksthatwere collected
Table 3 Growth parameters of hLZ transgenic and non-transgenic control animals consuming milk from hLZ transgenic or non-
transgenic control does
CC
a CT
b TC
c TT
d
Overall gain birth to wean (kg)
Females 20.42 ± 1.01
(n = 6)
19.15 ± 3.42
(n = 8)
19.74 ± 3.10
(n = 5)
21. 32 ± 2.39
(n = 4)
Males 23.35 ± 3.28
(n = 9)
24.09 ± 3.13
(n = 8)
24.85 ± 2.92
(n = 5)
22.89 ± 3.55
(n = 7)
Weaning weight (kg)
Females 24.40 ± 0.94
(n = 6)
22.61 ± 3.75
(n = 8)
23.27 ± 2.73
(n = 5)
25.11 ± 2.42
(n = 4)
Males 27.22 ± 3.84
(n = 9)
27.73 ± 3.40
(n = 8)
28.91 ± 3.19
(n = 5)
26.82 ± 3.32
(n = 7)
Slope of gain (kg/day)
Females 0.22 ± 0. 03
(n = 6)
0.18 ± 0.03
(n = 8)
0.23 ± 0.03
(n = 5)
0.20 ± 0.02
(n = 4)
Males 0.22 ± 0.03
(n = 9)
0.23 ± 0.02
(n = 8)
0.24 ± 0.04
(n = 5)
0.25 ± 0.05
(n = 7)
Post-wean gain (kg)
Females NA
e 16.31 ± 4.23
(n = 8)
NA
e 17.02 ± 3.68
(n = 4)
Males 17.72 ± 7.90
(n = 7)
13.47 ± 4.34
(n = 7)
14.35 ± 5.52
(n = 5)
20.00 ± 8.77
(n = 3)
a Non-transgenic control animals consuming milk from non-transgenic does
b Non-transgenic control animals consuming milk from hLZ transgenic does
c hLZ transgenic animals consuming milk from non-transgenic does
d hLZ transgenic animals consuming milk from hLZ transgenic does
e Not statistically analyzed due to small group size (\3 animals)
Table 4 Semen parameters from hLZ transgenic and non-transgenic control bucks
Volume (ml) Concentration (billions
sperm/ml ejaculate)
Total sperm
per ejaculate
Morphology
(% normal)
Viability
(% live)
Control (n = 12) 0.84 ± 0.28 2.57 ± 1.69 2.36 ± 2.02 88.43 ± 5.34 76.04 ± 11.48
Transgenic (n = 12) 1.00 ± 0.25 3.20 ± 1.74 3.34 ± 2.25 88.10 ± 5.92 82.35 ± 9.19
No signiﬁcant differences were detected between control and transgenic animals (P[0.05)
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whether normal reproductive status was maintained
beyond the ﬁrst breeding season. No gross deviations
between the years for either buck were evident.
In Table 7, a summary of the reproductive status
of does in the hLZ line is represented by their kidding
history. There were no signiﬁcant differences in the
parameters of days of gestation (P = 0.20), live kids
born (P = 0.39) and total kids born (P = 0.22)
among groups of non-transgenic control does and
hLZ transgenic does. There were no signiﬁcant
differences in the number of dead kids born among
transgenic and non-transgenic does (v
2 = 0.544,
P[0.05).
Discussion
Studies such as this one that examines basic functions
will be useful in determining the impact of GE on
animal health. It has been suggested that three aspects
of the welfare of a transgenic line should be evaluated
including the effects of insertional mutagenesis,
transgene expression and, if applicable, effects of in
vitro reproduction technologies if somatic cell nuclear
transfer techniques were used to generate the trans-
genic line (Van Reenen 2009). As the hLZ transgenic
line was generated by pronuclear microinjection,
insertional mutagenesis and transgene expression
would be of concern. Copy number as determined
by real-time PCR along with transgene insertion site
mapping results via an inverse PCR strategy have
veriﬁed that two copies of the as1HLZ transgene are
integrated into the genome in a head-to-tail fashion.
Analysis of the sequence at the 30 insertion site by
BLAST indicates that the transgene is not integrated
into any currently known genes (data not shown). As
the goat genome has yet to be sequenced, the majority
of the matches were with bovine genomic repetitive
DNA analogous to the L1-art repeat family. Further-
more, preliminary analysis of mRNA from a tissue
panel (ear, skin, muscle, fat, mammary gland, liver,
kidney, spleen, salivary gland, heart, lung, uterus,
ovary and intestine) from three individual lactating
transgenic females by reverse transcriptase PCR
demonstrated that expression of the transgene was
restricted to the lactating mammary gland (data not
shown). Therefore, we would not anticipate any major
impact resulting from insertional mutagenesis or off-
tissue expression of the transgene on the general
welfare of this line of transgenic animals.
To begin to evaluate aspects of animal welfare of
the hLZ transgenic line, relevant measures of welfare
would comprise assessing general measures such as
Table 5 Semen motility of control and hLZ transgenic bucks
Total
motility (%)
Total progressive
motility (%)
Control (n = 9) 64.28 ± 15.26 39.65 ± 14.14
Transgenic (n = 5) 60.00 ± 17.93 35.07 ± 14.04
No signiﬁcant differences were detected between control and
transgenic animals (P[0.05)
Table 6 Reproduction
parameters of yearling and
mature transgenic males
Volume
(ml)
Viability
(%)
Morphology
(% normal)
Concentration
(sperm/ml
ejaculate)
Total sperm/
ejaculate
(billions)
Buck 7028
Yearling 0.75 80 88 3.03 2.44
Mature 1.50 76 90 4.65 6.97
Buck 7032
Yearling 1.07 84 89 4.75 5.11
Mature 1.00 90 91 6.10 6.10
Table 7 Kidding history of the hLZ transgenic line
Gestation
(days)
Live born Total born
Control
(n = 9)
152.20 ± 4.15 2.38 ± 0.92 2.56 ± 0.75
Transgenic
(n = 15)
151.22 ± 3.91 1.98 ± 0.78 2.21 ± 0.71
No signiﬁcant differences were detected between control and
transgenic animals (P[0.05)
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123health (clinical signs of disease), production traits,
reproduction and growth (Broom 1993). Here, several
parameters associated with reproduction and growth
of hLZ transgenic and non-transgenic dairy goats
were evaluated to assess the ﬁtness of this line of
transgenic dairy goats when compared with their
control siblings. None of the reproductive traits,
growth periods, or rate of growth were affected by
presence of the transgene, or the consumption of milk
from hLZ transgenic does.
Growth
In agreement with our data on insertion site, the site
of integration of the transgene did not appear to
interrupt an endogenous gene for growth in utero,
as both groups of animals, transgenic and non-
transgenic controls, demonstrated no signiﬁcant dif-
ferences in birth weights. The males did have, on
average, higher birth weights than the females for
both groups, as is common in most mammals
(Lawrence and Fowler 1997). In addition, there were
no differences in birth weights detected during the
3 years of the trial, indicating that any environmental
differences between the years of the study had no
impact on the prenatal growth of the kids.
Overall gain from birth to weaning was not
signiﬁcantly different for either the males or the
females among groups. There were also no differ-
ences detected by year of the trial or birth weight for
overall gain. These results indicate that all groups of
animals, whether transgenic or not, and whether
drinking control or transgenic milk, gained mass in a
similar manner from their birth to weaning. As with
birth weights, the gain in these animals realized
between birth and weaning was higher on average for
males than for females.
Weaning weights in females although not signif-
icantly different among groups, demonstrated a
difference among years of the study. Weaning
weights were lowest in 2006, but not signiﬁcantly
different from weaning weights in 2008. The differ-
ence in weaning weights of does in the feeding trial in
years 2006 and 2007 could have been due to such
factors as management changes which occurred
between these 2 years and the genetics of the non-
transgenic control animals used for breeding. Since
no differences were detected in the weaning weights
among the groups, the co-variables that contributed to
the differences seen among mean weaning weights
between 2006 and 2007 do not indicate differences
due to animal or milk type. Since a variety of non-
transgenic control bucks were used to generate the
new crop of kids each year, genetics of the sires may
have contributed to the differences in mean weaning
weights demonstrated between the ﬁrst 2 years of the
trial. There were no signiﬁcant differences in wean-
ing weights detected among the groups of males, and
year effects did not signiﬁcantly affect the weaning
weight in males.
The rate at which the groups of both males and
females gained weight was not signiﬁcantly different,
except by year of the trial in both males and females.
The average rate of gain for the does in the study
ranged between 0.18 and 0.23 kg per day, well
within the range of 0.02–0.3 kg per day reported
in the literature for growing female kids (National
Research Council 2006). In males, the slope of
gain from birth to weaning ranged from an average
of 0.22–0.25 kg per day, compared with 0.02–
0.30 kg per day reported in the literature for male
dairy goats of similar age (National Research Council
2006).
The comparisons of non-transgenic animals and
transgenic animals drinking either hLZ milk or
control milk demonstrated that all groups grew
similarly. This line of transgenic dairy goats appears
to have a normal pattern of growth during both the
prenatal and postnatal period when compared with
their full-sibs which do not carry the transgene. The
consumption of milk from hLZ transgenic dairy goats
does not appear to negatively impact growth in either
males or females in this line of transgenic dairy goats,
nor their non-transgenic siblings.
Details of illness, disease outbreaks and injuries,
were maintained during the duration of the trial.
Scours outbreaks occurred twice in 2007, once in a
pen of control kids, and once in a pen of transgenic
kids, resulting in diarrhea, dehydration and inappe-
tance in the affected animals. Treatment (Albon) was
administered as recommended by the clinical veter-
inarian, and the animals returned to a healthy status.
Over the 3 years, a total of six animals (three
transgenic and three non-transgenic controls) did
not complete the trial and either died or were
euthanized. The three transgenic kids (all consuming
control milk) were all euthanized due to physical
ailments/defects. One kid suffered a broken leg, one
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123had a congenital central nervous system defect and
one was a hermaphrodite. All of these conditions are
noted to occur in the general goat population and our
herd records gave no indication that transgenic
animals were more likely to suffer these conditions
than their non-transgenic herdmates. In contrast, the
three non-transgenic kids all died due to bacterial
infections with the causes of death being either
enteric coccidiosis or enterotoxemia caused by Clos-
tridium perfringens. It is interesting to note that the
three animals which died due to bacterial-related
issues of the gastrointestinal tract were all consuming
non-transgenic milk. This may indicate an improved
resistance to common gastrointestinal infections
caused by microorganisms in animals which consume
hLZ milk. Although no formal statistical analysis was
applied to the information gathered on death and
illness in the trial animals, the heath of the transgenic
animals did not appear to be any different than their
control siblings, or different from goats in other dairy
goat populations that are subject to the same types of
diseases, defects and injuries.
Overall, neither the consumption of hLZ trans-
genic milk nor the presence of the hLZ transgene in
the genome of the hLZ line of dairy goats caused
detrimental effects on birth weight, weaning weight,
overall gain or rate of gain. Although some differ-
ences were found among groups in the feeding trial
over 3 years due to year effects, there is no pattern of
consistently altered growth in any group, and in fact
the rate of gain for all groups of both sexes is
relatively high when compared with the industry
average.
Reproduction—males
Bucks from the hLZ transgenic line were not
signiﬁcantly different from non-transgenic control
bucks in their reproductive ability. The values for the
semen traits of both the control and transgenic bucks
were within the normal range for goats; volume 0.1–
1.5 ml, concentration 2–6 billion sperm per ml
ejaculate, viability 82–93%, normal morphology
80–95% and total motility 54–80% (Hafez 1980;
Hafez and Hafez 2000; Nur et al. 2005). In addition,
normal maturation of semen quality with increasing
age was demonstrated in two hLZ transgenic bucks
which had semen analyzed and compared in both
their ﬁrst and second breeding seasons.
Over the 3 year period, a total of ﬁve animals were
available but could not successfully be collected.
Two transgenic and two non-transgenic controls were
never successfully collected due to behavioral prob-
lems (unwilling and/or unmanageable behavior) and
one non-transgenic control failed to show any signs
of breeding behavior. Overall, the presence of the
hLZ transgene in the genome of these animals does
not appear to interfere with normal semen production.
Similar ﬁndings have been reported for transgenic
cattle and rabbits (Richt et al. 2006; Chrenek et al.
2007).
Reproduction-females
No signiﬁcant differences were detected between the
hLZ transgenic does and the non-transgenic controls
in any of the recorded reproductive parameters. No
transgenic doe gave birth to a litter that exceeded
three neonates and litter size was not signiﬁcantly
different from the control does. The number of dead
born kids to the transgenic line was also not
signiﬁcantly different from control animals. The only
sexual aberration identiﬁed in this study was the
hermaphrodite transgenic female born in 2008. In
livestock this condition is most common in cattle,
goats and pigs (Bliss et al. 1992) and has been seen in
our control goat population as well.
Other parameters of female reproductive ﬁtness,
such as a fertilization assay which would demonstrate
both the efﬁciency of the sperm’s ability to fertilize
the egg, and the quality of the egg itself are more
invasive measures that could be taken to examine the
reproductive health of this line of transgenic goats,
but as we require lactating females for the study of
the applications of this line, this type of work was not
carried out for this study. However, the production of
the same total number of kids born to both the non-
transgenic control does and the hLZ transgenic does
over 8 years demonstrates the efﬁciency of repro-
duction of the hLZ transgenic does.
The evaluation of the health, well-being and
behavior of transgenic animals are important aspects
of deﬁning the safety of applying transgenic technol-
ogy to animal agriculture. While it is likely that large
numbers of animals may be required to detect a small
but biologically signiﬁcant impact on welfare, dele-
terious effects could be identiﬁed with fewer study
subjects (Van Reenen 2009). In this study, we report
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123no major differences in the tested parameters of
reproductive efﬁciency or growth of the line. This
coupled with our previous characterization of the line
suggests that standard reproduction indices and
weight development in this line of transgenic goats
are not compromised due to the presence and
expression of the transgene. Information of this
nature can help contribute to the knowledge required
to make science-based regulatory decisions regarding
the use of transgenic animals in agriculture. The
ability to create a line of animals with novel and
beneﬁcial products will only be accepted for use by
consumers and regulators if the general good health
and well-being of the animals has been established.
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